New patent expiration for Galderma Labs drug ORACEA
Annual Drug Patent Expirations for ORACEA Oracea is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers. There are six…
Source
Annual Drug Patent Expirations for ORACEA Oracea is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers. There are six…
Source
EXSERVAN (riluzole) Aquestive Patent: 8,603,514 Expiration: Apr 3, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
Source